This afternoon’s discussion will focus on the question: is the MPharm still fit for purpose? We’ve seen lots of changes to the MPharm in recent years to stay in line with the shift in pharmacy practice away from dispensing and towards clinical services. But is the MPharm keeping pace with changes to everyday pharmacy practice? And is the shift towards independent prescribing in undergraduate degrees the right move? So, where along the spectrum do your own views lie? Join the Big Debate to tell us what you think. We’re expecting lots of your will want to share your views on this important topic. Simply type your comment or question into the ‘leave a reply’ box below and let us know what you think. The “live” part of the debate will close at 2pm, but feel free to continue to exchange views for as long as you like. Join your pharmacy peers this afternoon to discuss: Whether the content of the MPharm is keeping up with the realities of modern pharmacy practice What fluctuating registration exam pass rates do and don't tell us about the quality of pharmacy education The pros and cons of baking independent prescribing training into the MPharm C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 1pm.

Would anybody be interested in a discussion for peer review? We can discuss possible topics. Thanks. 

Through our Pharmacist Support ACTNow wellbeing campaigns we want to increase awareness of issues impacting wellbeing across the sector. Our 2023 Pharmacist focused campaign focuses on tackling some of the issues highlighted through our research around workplace culture and stigma,  with activities based around the broad theme of supporting a positive workplace culture. In week one of our campaign, themed Breaking the silence - we want to stimulate conversations and will be sharing stories from teams, managers and individuals across the sector highlighting how they’ve supported colleagues and one another with their wellbeing. We're keen to hear your thoughts and experiences too! Tell us What you feel causes stress or impacts staff mental health at work? And what contributes to wellbeing at work?

Tonight’s discussion will focus on the question: should pharmacist recruitment into the additional roles reimbursement system (ARRS) be halted? The ARRS, introduced in England in 2019, reimburses primary care networks (PCNs) for the salaries of several healthcare professionals – including pharmacists – as a way to help build multidisciplinary teams. The scheme has proven controversial over the past year or so. While ARRS advocates have defended it as a means by which pharmacists can gain experience working in a multidisciplinary setting, its detractors have warned of an exodus of community pharmacists as many flock to work in primary care. Some representative groups have even called for an end to the ARRS in light of “urgent…workforce issues” in community pharmacy, while others have suggested the need for pharmacy to have its own equivalent of the ARRS. But with community pharmacy’s future seemingly defined by the introduction of more clinical services, it seems clear that pharmacists’ role as the experts in medicine will become more important than ever - with PCNs eager to harness these skills. So, where along the spectrum do your own views lie? Join the Big Debate to tell us what you think. We’ve got two speakers lined up to share their views tonight, but you can also let us know your thoughts by commenting and asking questions. The “live” part of the debate will close at 8pm, but feel free to continue to exchange views for as long as you like. Join your pharmacy peers tonight to discuss: - The impact ARRS recruitment has had on community pharmacy - How it is affecting primary care - The benefits of working in general practice pharmacy - What can be done to make jobs in community pharmacy more attractive C+D has introduced a streamlined functionality that allows users to mention each other in a comment. Simply use ‘@’ and type in the person’s name. This debate will start at 7pm.

I’m finding it difficult to find a peer for peer review. Would anyone be keen to set up a group?  Thanks 

‘Unopposed’ rural pharmacy sold to first-time buyers after fetching multiple bids  An “unopposed” pharmacy in a rural Welsh village that attracted lots of interest from potential buyers has been sold, specialist broker Hutchings has announced.  Revealed: The full shortlist for the C+D Awards 2023  C+D has revealed the full shortlist for its sixteenth annual awards, taking place in London on September 6.   What can England's community pharmacists learn from their international peers?  A trip away has Beth Kennedy thinking about what community pharmacists in England could learn from international models of pharmacy  And the winner is... C+D unveils your new Xrayser  C+D readers voted in their droves for the writer they wanted to become the next anonymous community pharmacy blogger Xrayser.